✦ LIBER ✦

44566 - Costs of drugs, disposables and volatile agents in routine anesthetics

✍ Scribed by Naveen Eipe; Susan Belo

Book ID: 105693536
Publisher: Springer-Verlag
Year: 2007
Tongue: French
Weight: 25 KB
Volume: 54
Category: Article
ISSN: 1496-8975
DOI: 10.1007/bf03019994

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Increased toxicity of the antitumor drug

Increased toxicity of the antitumor drug cyclophosphamide in mice in the presence of the volatile anesthetic agent halothane

✍ Scott Rosenow; Kimberly L. Kooistra; Garth Powis; Russell A. Dyke 📂 Article 📅 1986 🏛 Springer 🌐 English ⚖ 758 KB

The precautionary principle: what is the

The precautionary principle: what is the risk of reusing disposable drops in routine ophthalmology consultations and what are the costs of reducing this risk to zero?

✍ Somner, J E A; Cavanagh, D J; Wong, K K Y; Whitelaw, M; Thomson, T; Mansfield, D 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 76 KB

Improved cost effective thin-layer detec

Improved cost effective thin-layer detection techniques for routine surveillance of commonly abused drugs in drug abuse urine screening and proficiency testing programs with built-in quality assurance

✍ K.K. Kaistha; R. Tadrus 📂 Article 📅 1983 🏛 Elsevier Science 🌐 English ⚖ 700 KB

Differences between a drug regimen emplo

Differences between a drug regimen employed in early phase 1 trials and the subsequent use of the agent in routine oncologic practice : A note of caution

✍ Maurie Markman 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 62 KB

It is reasonable to assume that a decision to permit wider access to new anticancer agents after the completion of only phase 1 trials will almost certainly result in the administration of such therapy to a substantial population of individuals who would not have been eligible for such “registration